Acrylamide does not induce tumorigenesis or major defects in mice in vivo

Journal of Endocrinology

Volumn 198, Issue 2, 2008, Pages 301-307

  Jin, Ling ^a   Chico Galdo, Vanessa ^a   Massart, Claude ^a   Gervy, Christine ^b   De Maertelaere, Viviane ^a   Friedman, Marvin ^c   Van Sande, Jacqueline ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADRENAL MEDULLA DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HORMONE INHIBITION; IN VIVO STUDY; MOUSE; NONHUMAN; PARALYSIS; PERIPHERAL NEUROPATHY; POLYDIPSIA; PRIORITY JOURNAL; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS; THYROTROPIN BLOOD LEVEL;

ACRYLAMIDE; ADRENAL MEDULLA; ANIMALS; BODY WEIGHT; FEMALE; METHIMAZOLE; MICE; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 51349091428     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0123     Document Type: Article

References (20)

1. Blasiak J, Gloc E, Wozniak K & Czechowska A 2004 Genotoxicity of acrylamide in human lymphocytes. Chemico-Biological Interactions 149 137-149.
2. Brooker G, Harper JF, Terasaki WL & Moylan RD 1979 Radioimmunoassay of cyclic AMP and cyclic GMP. Advances in Cyclic Nucleotide Research 10 1-33.
3. Bull RJ, Robinson M, Laurie RD, Stoner GD, Greisiger E, Meier JR & Stober J 1984 Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Research 44 107-111.
4. Chai CK 1978 Spontaneous amyloidosis in LLC mice. American Journal of Pathology 90 381-397.
5. Chico Galdo V, Massart C, Jin L, Vanvooren V, Caillet-Fauquet P, Andry G, Lothaire F, Dequanter D, Friedman M & Van Sande J 2006 Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures. Molecular and Cellular Endocrinology 257-258 6-14.
6. Collins JJ, Swaen GM, Marsh GM, Utidjian HM, Caporossi JC & Lucas LJ 1989 Mortality patterns among workers exposed to acrylamide. Journal of Occupational Medicine 31 614-617.
7. Foth H, Degen GH & Bolt HM 2005 New aspects in the classification of carcinogens. Arhiv za Higijenu Rada i Toksikologiju 56 167-175.
8. Friedman MA, Dulak LH & Stedham MA 1995 A lifetime oncogenicity study in rats with acrylamide. Fundamental and Applied Toxicology 27 95-105.
9. Fullerton PM & Barnes JM 1966 Peripheral neuropathy in rats produced by acrylamide. British Journal of Industrial Medicine 23 210-221.
10. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA & Mast RW 1986 Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicology and Applied Pharmacology 85 154-168.
11. Khan MA, Davis CA, Foley GL, Friedman MA & Hansen LG 1999 Changes in thyroid gland morphology after acute acrylamide exposure. Toxicological Sciences 47 151-157.
12. Lafferty JS, Kamendulis LM, Kaster J, Jiang J & Klaunig JE 2004 Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat. Toxicology Letters 154 95-103.
13. Marsh GM, Lucas LJ, Youk AO & Schall LC 1999 Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occupational and Environmental Medicine 56 181-190.
14. Mucci LA, Dickman PW, Steineck G, Adami HO & Augustsson K 2003 Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. British Journal of Cancer 88 84-89.
15. Perret J, Ludgate M, Libert F, Gerard C, Dumont JE, Vassart G & Parmentier M 1990 Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochemical and Biophysical Research Communications 171 1044-1050.
16. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J & Refetoff S 1999 Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid 9 1265-1271.
17. Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, Macdonald N, Clewell H, Allen B & Van Landingham C 2006 Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Critical Reviews in Toxicology 36 481-608.
18. Sumner SC, MacNeela JP & Fennell TR 1992 Characterization and quantitation of urinary metabolites of [1,2,3-13C)acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chemical Research in Toxicology 5 81-89.
19. Tanii H & Hashimoto K 1983 Neurotoxicity of acrylamide and related compounds in rats. Effects on rotated performance, morphology of nerves and neurotubulin. Archives of Toxicology 54 203-213.
20. Tyl RW, Marr MC, Myers CB, Ross WP & Friedman MA 2000 Relationship between acrylamide reproductive and neurotoxicity in male rats. Reproductive Toxicology 14 147-157.